Rhumbline Advisers Teva Pharmaceutical Industries LTD Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Rhumbline Advisers holds 287,401 shares of TEVA stock, worth $4.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

287,401

Previous 281,062 2.26%

Holding current value

$4.77 Million

Previous $4.32 Million 11.51%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$12.82 - $18.15 $81,265 - $115,052	6,339 Added 2.26%	287,401 $4.82 Million
Q1 2025 Apr 08, 2025	BUY	$14.67 - $22.01 $31,217 - $46,837	2,128 Added 0.76%	281,062 $4.32 Million
Q4 2024 May 29, 2025	SELL	$16.43 - $22.77 $34,963 - $48,454	-2,128 Reduced 0.76%	278,934 $6.15 Million
Q4 2024 Jan 30, 2025	SELL	$16.43 - $22.77 $708,954 - $982,525	-43,150 Reduced 13.4%	278,934 $6.15 Million
Q3 2024 Nov 12, 2024	SELL	$15.81 - $18.96 $261,987 - $314,186	-16,571 Reduced 4.89%	322,084 $5.8 Million
Q2 2024 Aug 01, 2024	SELL	$12.78 - $17.4 $30,620 - $41,690	-2,396 Reduced 0.7%	338,655 $5.5 Million
Q1 2024 May 09, 2024	BUY	$10.67 - $14.43 $88,123 - $119,177	8,259 Added 2.48%	341,051 $4.81 Million
Q4 2023 Feb 08, 2024	BUY	$8.12 - $10.63 $274,391 - $359,208	33,792 Added 11.3%	332,792 $3.47 Million
Q3 2023 Nov 09, 2023	BUY	$7.48 - $10.7 $250,101 - $357,765	33,436 Added 12.59%	299,000 $3.05 Million
Q2 2023 Aug 08, 2023	BUY	$7.2 - $9.47 $1.91 Million - $2.51 Million	265,564 New	265,564 $2 Million
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $118,865 - $176,010	-13,870 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $112,624 - $181,974	13,870 New	13,870 $171,000

Others Institutions Holding TEVA

# of Institutions

653

Shares Held

663M

Call Options Held

30.2M

Put Options Held

16.4M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Teva Pharmaceutical Industries LTD Transaction History